LRF Urges CDC to Prioritize Blood Cancer Patients for COVID-19 Vaccine
LRF Urges CDC to Prioritize Blood Cancer Patients for COVID-19 Vaccine VISIT THE COVID-19 LEARNING CENTER FOR…
Advocacy News
Why the U.S. Needs Non-Profits Now More Than Ever
By Michael Werner and Christina Kazhe The COVID-19 pandemic has brought the country to a…
LRF Advocates for Patient Access to Cellular Therapies
On November 2, 2019, the Lymphoma Research Foundation sent a letter to Donald Thompson, Director, Division of Acute Care at the Centers for Medicare and Medicaid Services requesting for MS-DRG reclassification for certain cases involving the use of chimeric antigen receptor T-cell (CAR T-cell) therapies.
Day of Action: Urge Congress to Support the Clinical Treatment Act
On July 10, the Lymphoma Research Foundation (LRF) is participating in a day of action…
Congress to Consider Federal Cancer Research Budget
Every year the National Institutes of Health (NIH) and National Cancer Institute (NCI) are required…
LRF Releases Monograph Addressing Early Career Scientist Crisis
In the face of declining federal and institutional resources, the Lymphoma Research Foundation’s (LRF) commitment…
Foundation Releases 2019 Public Policy Agenda Outlining Policy Priorities For Year Ahead
The Lymphoma Research Foundation (LRF) is proud to be a national thought leader in the…
Foundation Hosts Biden Cancer Community Summit to Address Funding for Early Career Researchers
As part of the Lymphoma Research Foundation’s ongoing efforts in support of early career lymphoma…
Buildings and Landmarks Worldwide Join LRF to Light It Red for Blood Cancer Awareness Month
Since 2011, the Lymphoma Research Foundation (LRF) has been a pioneer in shedding a “light”…
Lymphoma Research Foundation Endorses the Cancer Care Planning and Communications Act
This month, the Lymphoma Research Foundation endorsed the bipartisan Cancer Care Planning and Communications (CCPC)…
Stay informed with news, alerts and other resources.
